Factor VIIa (Systemic)
Brand Names : NovoSeven, coagulation factor VIIa (recombinant), eptacog alfa, factor 7, proconvertin, recombinant activated factor VIIa, recombinant coagulation factor VIIa, recombinant factor VIIa, rFVIIa.
CategoryDescriptionFactor
VIIa is a man-made protein produced to replicate the naturally occurring activated
factor VII (factor VIIa) in the body. Factor VIIa is used to stop bleeding
of injuries for patients with hemophilia by helping the blood to clot. This
man-made protein, factor VIIa, is used in people who have Hemophilia A or
Hemophilia B, who have also formed antibodies against other clotting proteins
that help bleeding to stop. Patients using factor VIIa are usually male.
Factor VIIa is to be administered only by or under the supervision of your
doctor or other health care professional. It is available in the following
dosage form(s):
Parenteral
-
Injection (U.S.)
Brand NamesSome commonly used brand names are:
In the U.S. -
Other commonly used names are coagulation
factor VIIa (recombinant)
, eptacog alfa
, factor 7
, proconvertin
, recombinant activated factor VIIa
, recombinant
coagulation factor VIIa
, recombinant factor VIIa
, and rFVIIa.
† Not commercially available in Canada.
|